KOC
EXAS

Koss-Olinger Consulting’s Exact Sciences EXAS Stock Holding History

Koss-Olinger Consulting’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,000
Closed -$622K – 250
2021
Q2 		$622K Hold
5,000
– – 0.09% 117
2021
Q1 		$659K Buy
+5,000
New +$684K 0.11% 104

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Koss-Olinger Consulting's EXAS Position: Q3 2021 in Review

Koss-Olinger Consulting sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 5,000 shares — an estimated $622K sold.

Koss-Olinger Consulting first reported a position in EXAS in Q1 2021 and held it in 2 quarters. The position peaked at $659K in Q1 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Koss-Olinger Consulting reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Koss-Olinger Consulting sold 5,000 Exact Sciences shares in Q3 2021, an estimated $622K.
  • Koss-Olinger Consulting first reported a position in Exact Sciences in Q1 2021 and held it in 2 quarters.
  • Koss-Olinger Consulting's Exact Sciences position peaked at $659K in Q1 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Koss-Olinger Consulting's 13F filing for Q3 2021, filed 9 Nov 2021.